Core Viewpoint - A class action securities lawsuit has been filed against agilon health, inc. due to alleged securities fraud affecting investors between February 26, 2025, and August 4, 2025 [1][2] Group 1: Allegations - The lawsuit claims that defendants made false statements and concealed information regarding the company's guidance for 2025, which they knew was unrealistic given industry challenges [2] - It is alleged that defendants overstated the financial benefits from strategic actions taken by agilon to mitigate risks, leading to misleading statements about the company's business and prospects [2] Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until March 2, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as a leading firm in securities litigation, with a team of over 70 employees [4] - The firm has been ranked in the Top 50 Report by ISS Securities Class Action Services for seven consecutive years, highlighting its expertise in complex securities cases [4]

Core Viewpoint - A class action securities lawsuit has been filed against agilon health, inc. for alleged securities fraud affecting investors between February 26, 2025, and August 4, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed information regarding the company's guidance for 2025, which they allegedly knew was unattainable due to industry challenges [2]. - It is alleged that the defendants overstated the financial benefits from strategic actions taken by agilon to mitigate risks, leading to materially false and misleading statements about the company's business and prospects [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until March 2, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant recoveries for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Agilon Health, Inc. regarding a class action lawsuit due to alleged misleading statements and guidance issued by the company during a specified period [1][3]. Group 1: Allegations - The complaint alleges that Agilon Health's management issued guidance for 2025 that was unrealistic given known industry challenges [3]. - It is claimed that the company overstated the immediate financial benefits from strategic actions intended to mitigate risks [3]. - As a result, the statements made by the defendants regarding Agilon's business and prospects were deemed materially false and misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as February 26, 2025, to August 4, 2025 [3]. - Shareholders are encouraged to register for the class action by March 2, 2026, to potentially be appointed as lead plaintiffs [4]. - Participation in the case does not incur any costs or obligations for the shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - The Law Offices of Howard G. Smith is investigating agilon health, inc. for potential violations of federal securities laws affecting investors [1] Company Summary - Agilon health, inc. (NYSE: AGL) is under scrutiny for possible legal claims related to investor losses [1] - Investors who have suffered losses in agilon health, inc. are encouraged to contact the law firm for potential claims [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance that led to significant investor losses [4][6]. Group 1: Allegations Against Agilon Health - The complaint alleges that agilon health and its executives made false and misleading statements, failing to disclose that they issued guidance for 2025 that was unrealistic given known industry challenges [6]. - It is claimed that the company materially overstated the financial benefits from strategic actions taken to mitigate risks, leading to misleading statements about its business and prospects [6]. - Following the release of disappointing second-quarter results on August 4, 2025, agilon health's stock plummeted by 51.5% the next day, reflecting the market's reaction to the disclosed information [7]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased agilon health securities between February 26, 2025, and August 4, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1][4]. - There is a deadline of March 2, 2026, for investors to seek the role of lead plaintiff in the federal securities class action against agilon health [4]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [8].

Core Viewpoint - The Portnoy Law Firm is advising investors of agilon health, inc. to participate in a class action lawsuit due to alleged corporate misconduct during the specified class period from February 26, 2025, to August 4, 2025 [1]. Group 1: Legal Action - Investors have until March 2, 2026, to file a lead plaintiff motion in the class action lawsuit [1]. - The Portnoy Law Firm is offering a complimentary case evaluation for investors to discuss their legal rights and options for recovering losses [2]. Group 2: Allegations Against the Company - The complaint alleges that agilon health, inc. failed to disclose that it issued guidance for 2025 that was unrealistic, given known industry challenges [3]. - It is claimed that the company materially overstated the financial benefits from strategic actions intended to mitigate risks [3]. Group 3: Company Events and Stock Impact - On August 4, 2025, agilon announced the resignation of Steven Sell as President, CEO, and Director, which was characterized as a termination without cause [4]. - Following the announcement of disappointing financial results on the same day, agilon's stock price plummeted over 50%, closing at $0.8801 on August 5, 2025 [4].

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Agilon Health, Inc. for alleged misrepresentations regarding the company's guidance for 2025, affecting investors who purchased securities between February 26, 2025, and August 4, 2025 [1][2]. Group 1 - The lawsuit claims that the defendants made misrepresentations concerning the company's issued guidance for 2025 [2]. - Investors who wish to serve as lead plaintiffs must file papers by March 2, 2026, but participation in any recovery does not require serving as lead plaintiff [3]. - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [4].

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is ...

Core Viewpoint - A class action lawsuit has been filed against agilon health, inc. for allegedly misleading investors about its business prospects and failing to disclose material industry challenges [1][2]. Group 1: Allegations and Company Performance - The complaint alleges that agilon health, inc. issued unrealistic guidance for 2025, knowing it was unlikely to be achieved due to significant industry headwinds [2]. - The company reportedly overstated the immediate financial benefits from strategic actions taken to mitigate risks [2]. - Following the announcement of disappointing financial results and the resignation of CEO Steven Sell on August 4, 2025, agilon's stock price plummeted over 50%, closing at $0.8801 on August 5, 2025 [3]. Group 2: Class Action Participation - Shareholders interested in serving as lead plaintiffs must submit their papers by March 2, 2026, to represent the class in the litigation [4]. - Shareholders can remain absent class members and still be eligible for recovery without participating in the case [4]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless a recovery is achieved [5].

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired Agilon Health, Inc. (“Agilon” or the “Company”) (NYSE: AGL) securities between February 26, 2025, and August 4, 2025. The Complaint alleges that (i) Defendants recklessly issued guidance for 2025 that they knew or should have known ...